[MYGN] QoQ Quarter Result on 30-Sep-2014 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
05-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -52.48%
YoY- -71.19%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 189,900 179,985 184,393 168,837 188,765 182,924 204,060 -4.69%
PBT 35,500 35,566 37,940 25,877 52,550 57,343 84,144 -43.83%
Tax 16,800 14,091 13,909 9,895 18,921 20,573 33,784 -37.31%
NP 18,700 21,475 24,031 15,982 33,629 36,770 50,360 -48.43%
Tax Rate -47.32% -39.62% -36.66% -38.24% -36.01% -35.88% -40.15% -
Total Cost 171,200 158,510 160,362 152,855 155,136 146,154 153,700 7.47%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 9.85 11.93 13.03 9.47 17.82 20.10 24.68 -45.88%
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
EPS 0.27 0.30 0.33 0.22 0.45 0.50 0.67 -45.53%
EPS Diluted 0.26 0.29 0.32 0.21 0.43 0.48 0.66 -46.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.